Literature DB >> 23625671

α1-Antitrypsin deficiency in a patient diagnosed with granulomatosis with polyangiitis.

Hanine Inaty1, Senada Arabelovic.   

Abstract

Granulomatosis with polyangiitis is a rare type of vasculitis that affects small-sized and medium-sized vessels. Any organ system can become affected, but it most commonly affects the upper airways, lungs and kidneys. The α1-antitrypsin deficiency is another rare disease that involves a genetic deficiency in the enzyme antitrypsin, which is produced in the liver and protects the lung against proteinases. The simultaneous occurrence of these two diseases is very rare and has been described. We present a case of granulomatosis with polyangiitis limited to the upper airways, and α1-antitrypsin deficiency occurring in the same patient. The patient presented with recurrent upper airway infections. The patient was treated with steroids and azathioprine which prevented recurrence of symptoms. High clinical suspicion of the concomitant occurrence of α1-antitrypsin deficiency in patients with vasculitis is essential to provide patients with adequate screening and treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625671      PMCID: PMC3645134          DOI: 10.1136/bcr-2013-009045

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Wegener's granulomatosis and alpha1-antitrypsin-deficiency emphysema: proteinase-related diseases.

Authors:  V T Barnett; M Sekosan; A Khurshid
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

2.  alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications.

Authors:  F Callea; G Gregorini; A Sinico; G G Consalez; G Gonzales; M Bossolasco; G Salvidio; A Radice; P Tira; G Candiano; G Rossi; A Petti; G Ravera; G Ghiggeri; R Gusmano
Journal:  Eur J Clin Invest       Date:  1997-08       Impact factor: 4.686

3.  Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency.

Authors:  P Mazodier; A N Elzouki; M Segelmark; S Eriksson
Journal:  QJM       Date:  1996-08

4.  Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.

Authors:  M A Audrain; R Sesboüé; T A Baranger; J Elliott; A Testa; J P Martin; C M Lockwood; V L Esnault
Journal:  Nephrol Dial Transplant       Date:  2001-01       Impact factor: 5.992

5.  Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis.

Authors:  V L Esnault; A Testa; M Audrain; C Rogé; M Hamidou; J H Barrier; R Sesboüé; J P Martin; P Lesavre
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

6.  Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.

Authors:  J A Savige; L Chang; L Cook; J Burdon; M Daskalakis; J Doery
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

  6 in total
  2 in total

1.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

Review 2.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.